I. Introduction
One of the central challenges for systems biology is the reconstruction of cellular processes from high-throughput experimental data. Much of the early work in this area was driven by the development of microarray technologies that allowed relatively comprehensive measurement of changes in mRNA expression. Using these data as proxies for changes at the protein level has generated many insights into the regulatory networks of the cell (Spellman et al. 1998; Segal et al. 2005; Ozsolak et al. 2011) . However, the actual correlation between the transcriptome and the proteome is unclear (Schwanhässer et al. 2011; Maier et al. 2009; de Sousa Abreu et al. 2009) , and more direct proteomic data are likely to provide a more reliable and thorough view of cellular processes.
Recently, technological advances have made it possible to directly measure proteomic changes at the global level. Mass-spectrometry (MS) techniques can quantify the relative levels of hundreds of peptides across multiple biological conditions (Choudhary et al. 2010; White 2008 ) and focused data collection on phosphoproteins was able to reveal the regulatory dynamics of cellular signaling networks at the level of the proteome (Grimsrud et al. 2010; Macek et al. 2009; Yi Zhang et al. 2007 ).
With new data come new challenges. Even in the best characterized responses there is poor overlap between hits identified by phosphoproteomics technologies and known pathway components. For example, in a study of phosphorylation changes that occur in response to mating pheromone in yeast (Gruhler et al. 2005) , 112 proteins contain differentially phosphorylated sites; of these, only 11 are known components of the expected mitogenactivated protein kinase (MAPK) cascade that responds to pheromone, and 76 were not present in any of the yeast pathways annotated in the KEGG PATHWAY database (Kanehisa et al. 2010) . Finding new ways to interpret these data could reveal previously unrecognized cellular pathways.
A second important challenge is to integrate transcriptional and proteomic data in order to observe the interplay between different layers of cellular signaling. For example, it may be possible to detect proteomic changes in signal transduction cascades that drive expression and also to reveal the resulting feedback of transcription on the proteome. But integrating these data will require novel computational approaches. Because regulation is mediated by diverse mechanisms, even the most comprehensive proteomics technologies cannot capture all these events. For example, MS based methods focusing on protein phosphorylation will fail to detect changes in other post-translational modifications such as acetylation, ubiquitination and sumoylation. Computational techniques are needed to discover proteins that participate in the signaling networks but are undetected in the experiments and also to provide insight into their functional roles. One successful approach has been to map these proteins onto known metabolic and regulatory pathways such as those curated in the KEGG PATHWAY (Kanehisa et al. 2010) and Reactome (Matthews et al. 2009) databases. This approach can reveal functional coherence and relevant biological processes from the data. However, as mentioned above, a large fraction of the phosphoproteomic data do not map to known pathway models, so we must turn to other approaches.
The interactome provides an alternative to using well-studied pathways. Advances in highthroughput experimental mapping of protein-protein interactions as well as efforts to extract known interactions from the literature have produced a number of large databases of protein interactions (selected examples are listed in Table I ). Despite being incomplete, especially for higher organisms, the amount of interaction data in these databases is still very large. Thus, it may be possible to discover unknown pathways among these interactions. While utilizing these large interactome datasets improves our ability to find connections among a set of proteins of interest, it also presents several challenges. First, the size of the potential network explodes exponentially and quickly becomes non-interpretable, as pointed out by previous data integration efforts (Hwang et al. 2005) . Secondly, interaction records in databases come from hundreds of laboratories and many experimental techniques of varying degrees of reliability (von Mering et al. 2002) , so overall the data quality is heterogeneous and should not be treated indiscriminately. Lastly, pooling these interactions together risks losing the specific context under which they were detected. It is with these issues in mind that we propose a constraint optimization approach for finding regulatory networks that are interpretable, reliable and biologically relevant.
Our method starts with a collection of protein-protein and protein-DNA interactions, which represent known or experimentally determined signaling and regulatory connections. It considers the observed phosphorylation events and differential gene expression as connectivity constraints that the reconstructed network must satisfy. Additionally, we take into account the different confidence levels among the interaction data sources by preferentially selecting the more reliable interactions. We show that these objectives can be formulated as a constraint network optimization problem, in particular, as a prize-collecting Steiner tree (PCST) problem on the interactome graph. Since the interactions are not limited to known pathways and the phosphorylation events and differential expressed genes are not limited to known players in these pathways, there is great potential for novel discoveries. On the other hand, all the interactions were experimentally determined and therefore have mechanistic basis that might become relevant in the current context. These two features of the method strike a balance between finding novel connections and revealing the relevance of known connections. We hypothesize that since each of our input data sources provides a different view of the molecular regulatory network, by putting them together we can generate high confidence hypotheses that have biological relevance and can be tested experimentally. This framework serves to organize these heterogeneous datasets and enhance our understanding of the cell at the systems level.
II. Computational methods
Network optimization is an area of computer science that has recently become very useful for analyzing biological problems, and a variety of algorithms are available to solve specific optimizations. The problem we have posed consists of finding a set of edges of minimum weight in order to connect a defined set of nodes (known as termini) in a weighted network. This problem is called the Steiner tree problem. An important generalization that allows some terminal nodes to be excluded is known as the prize-collecting Steiner tree (PCST) problem. For our purpose, we will use a network in which edge weights reflect our confidence in the interactions and where terminal nodes represent hits from the experiments, i.e., phosphorylated proteins and differentially expressed transcripts. In this setting, the solution to the PCST optimization is a set of most confident interactions that link together the hits while possibly leaving some unconnected [ Figure 1(A) ].
Although the concept of Steiner tree has been previously applied to biological networks (Dittrich et al. 2008; Scott et al. 2005) , we note that our approach is distinctive in multiple aspects. First, instead of mRNA transcript abundance we use protein level measurements on nodes in the interactome, which provides a much more accurate representation of the underlying biological processes. Second, we explicitly model the confidence of individual edges in the interactome to account for the uncertainties in the interaction data. Third, we do not require all nodes in the solution to be detected in the experiments, allowing our approach to compensate for multiple sources of noise. This last feature is absent in an application of a Steiner tree like algorithm to build a high confidence network with genetic screening hits as terminal nodes (Yosef et al. 2009) . A minimum-cost flow optimization approach connects genetic hits to differentially expressed genes (Lan et al. 2011; Yeger-Lotem et al. 2009 ) but the result is less compact than the PCST . We now describe the process of constructing the optimization problem, solving it and analyzing the results. We also offer some advice on practical matters such as tuning the parameter values and visualizing the network.
A. Setting up the prize-collecting Steiner tree
We treat the interactome as an undirected graph G = (V, E) where nodes are proteins or genes and edges represent the known interactions. Each node ν ∈ V is associated with a penalty π ν ≥ 0. Protein nodes to which experimental data are mapped receive positive penalty values and therefore are termini for the PCST. All other nodes receive zero penalties. As the magnitude of the penalty value increases the more confident we are that the protein/gene was experimentally detected as relevant in the signaling response. The algorithm is forced to pay a penalty each time it leaves a terminal out of its final network. This constraint causes the network to include as many high-confidence nodes as possible. However, this constraint alone would lead to very large networks that might contain many unreliable edges. So we also assign to each edge e ∈ E a cost c e ≥ 0 that is inversely related to our confidence in each interaction.
We aim to find a subtree F = (V F ,E F ) of G that minimizes the objective function Because we incur penalties for excluding nodes while paying costs for including edges, the algorithm will be forced to favor connecting high-confidence data with high-confidence interactions. We further introduce a scaling parameter β to balance the penalties and the edge costs:
We may solve this optimization problem exactly by using the branch-and-cut approach (Ljubić et al. 2005) implemented in the dhea-code software program that calls the ILOG CPLEX mathematical programming solver. As an alternative to solving it as an integer linear program, an approach from statistical physics (Bayati et al. 2008 ) has resulted in new heuristic algorithms based on message-passing techniques (Bailly-Bechet et al. 2011) . We now describe how the experimental data are transformed into input for the algorithm. An overview of the work flow is in Figure 1(B) .
B. A probabilistic interactome

This is
Step 1 in Figure 1 (B). The set of edges E of the input graph G consists of direct (physical) protein-protein interactions found in databases of molecular interactions such as those listed in Table I . To assign confidence values for these interactions, a few methods have been previously published Orchard et al. 2007; Jansen et al. 2003 ).
Here we use a naïe Bayes probabilistic model (Jansen et al. 2003) . Interaction between two proteins is modeled as random variable i ∈ {0,1} with i = 1 when two proteins interact and i = 0 otherwise, and each kind of experimental evidence is modeled as a random variable f j ∈ {0,1} where f j = 1 indicates f j is observed and f j = 0 otherwise. From published gold standard sets of positive (Yu et al. 2008 ) and negative interactions (Jansen et al. 2003) we can compute the conditional probability table for each kind of evidence, P(f j |i). Then, for each interaction e supported by a set of experimental evidence F e = {f e,j |j = 1,…, n}, assuming independence between the evidence we have and a straight forward application of Bayes rule gives the probability that this interaction is real:
The cost c e on edge e that is input into the PCST objective function is
C. Determining transcription factor targets
Transcription factor to mRNA target relationships are added to the protein-protein interactome to form the total interactome [Step 2 in Figure 1 (Harbison et al. 2004; MacIsaac, T. Wang, et al. 2006) . The human and mouse ENCODE projects (Birney et al. 2007 ) represent systematic efforts to generate ChIP profiles for multiple transcription factors in a variety of human cell lines and mouse tissues. Computationally, transcription factors often have sequence specificities that allow binding sites to be predicted to some extent ( Figure 6 ). Commonly used quantitative representation of such binding patterns, also known as sequence motifs, include position weight matrices (PWM)/position specific scoring matrices (PSSM) (D'haeseleer 2006; Stormo 2000) with an information theoretic perspective, and position specific affinity matrices (PSAM) with a statistical mechanics perspective (Foat et al. 2006 (Foat et al. , 2005 Manke et al. 2008; Roider et al. 2007) . Motifs from the TRANSFAC (Wingender 2008; Matys et al. 2006 ) and JASPAR (Sandelin et al. 2004; Bryne et al. 2008 ) databases, which collect published transcription factor binding motifs from the literature, can be used for predicting regulatory elements. Once a genomic region is determined to be bound by a transcription factor based on experimental and/or computational evidence, nearby genes can be associated with this factor as its potential downstream targets, and we add to the interactome edges going from the transcription factor (a protein node) to these target mRNA nodes.
D. Node penalties
This is
Step 3 in Figure 1 (B). We define two kinds of penalties for proteins in the interactome: one at the protein level derived from the phosphoproteomics MS data, and the other at the mRNA level derived from mRNA expression data.
Although published phosphoproteomic MS datasets often provide the identities of the proteins that contain the peptide sequences inferred from the MS spectra, it is still advisable to map the peptides to a database of protein sequences from which the interactome dataset is derived in order to avoid issues such as inconsistencies in mapping gene identifiers and in treating protein isoforms. This can be achieved by finding protein sequences in a database that contain matches to the peptide sequences, for example, by the sequence alignment search tool BLAST (Altschul et al. 1990 ) with parameter settings optimized for matching short peptide sequences. In an analysis comparing two conditions, proteins that contained perfect alignment to a peptide sequence receive a positive penalty value that is proportional to the absolute value of log fold change in phosphorylation between the conditions of interest. If one peptide sequence is aligned to multiple proteins in the interaction graph, all these proteins receive the same penalty value. If multiple phosphorylated peptide sequences are perfectly aligned to one protein, the maximum fold change in phosphorylation of these peptides is used to calculate the penalty value for this protein. Other methods of assigning penalties are also possible and are discussed below.
For penalty values on mRNA nodes, some modifications to the interactome are required to make the resulting network more biologically realistic. If we simply put penalty values on the mRNA nodes, the tree structure of the solution network means that any one mRNA node is connected to at most one upstream transcription factor. Such a network cannot capture one gene being targeted by multiple transcription factors, which is a common feature of transcriptional regulation. Instead, we represent multiple transcription factors bound to the same gene with separate nodes. Let M be the set of differentially expressed transcripts, and fc(m) be the fold change in mRNA abundance of each gene m ∈ M. For each m, we searched the interactome for the set of upstream transcription factors F that target m, remove m from the interactome, and add one node m f for each transcription factor f ∈ F and one edge between f and m f . The fold change of m is transferred to all the m f to compute the penalty values on m f . Each new terminal node m f may be interpreted as a binding site of f on m.
E. Sensitivity analysis
Applying an optimization approach to inherently noisy biological data makes it necessary to explore the alternative or sub-optimal solution space surrounding the reported optimal solution. This is to ensure that the nodes and edges selected by the algorithm, from which significant efforts will be invested to extract biological meaning, are relatively stable to possible sources of noise. Figure 3 presents two ways to quantify this stability at the global level. First, starting from the optimal solution reported by the algorithm, we can reformulate the optimization problem to find a number of sub-optimal solutions -networks that are optimal under the additional constraint that they must differ from the original optimal solution by a pre-defined percentage of nodes. We can then compare these suboptimal solutions to the optimal one in terms of the objective function value [ Figure 3 (A)] and the frequency at which the nodes in the original optimal solution are preserved in the sub-optimal solutions [Figure 3(B) ] in order to decide whether the solution is robust to noise.
F. Practical advice
Parameters: Tuning the value of parameter β essentially controls the size of the PCST solution output. With larger β values it becomes more expensive to exclude each terminal node (i.e., making the objective function larger), so the optimization algorithm will include more edges in the PCST solution. Although a larger network may include more hits from the experimental data, it is more difficult to interpret and also more likely to include false positive hits that may connect to the real underlying network via tenuous interactions. To find a suitable value of this parameter, it is advisable to run the algorithm with a range of values and choose a solution that (1) includes any expected pathways based on prior biological knowledge, (2) is stable for the neighborhood of β values, and (3) contains as many of the hits as possible. One can also start with a small value of β to build a core network and gradually increase β to explore how more hits are connected to the core network.
It may be possible to use cross-validation to objectively choose β. In such an approach, one would randomly partition the terminal nodes into two complementary subsets, build a PCST using one subset (training set) and compute the recovery of the second subset (validation set) in that PCST. To reduce the effect of random variations, for each value of β, multiple rounds of such cross-validation can be performed and one average performance value is reported. Based on this performance measure, a β value can be selected.
While this approach has a certain appeal, we urge caution since the assumptions and requirements of cross-validation may not be satisfied by the biological datasets. First, in order for the recovery of the validation set by a PCST to be a good indicator of its performance, the training set and the validation set must be drawn from the same distribution. This criterion requires the terminal sets to be sufficiently large that each random sample contains termini from all the underlying biological processes. Since the current datasets are subject to many limitations such as the sensitivity of the MS instrument depending on protein abundance and the coverage of the interactome, we do not know a priori whether this assumption is appropriate. Second, it is unclear which of the conventionally used measures of predictor performance is suitable in this setting. We aim to recover intermediate nodes that are undetected in experiments, so we cannot count such nodes included in the PCST as false positives. In the absence of a false positive definition, counting the recovery of the terminal nodes makes little sense since the optimal value of β will be the one that produces a PCST that include the most terminal nodes (weighted by penalty values).
Implementation: There are various approximation algorithms to solve the PCST problem. These have recently been reviewed (Archer et al. 2011 ). The dhea-code program (Ljubić et al. 2005) , which can be downloaded from Dr. Ljubić's website (Ljubić 2008) , uses a branchand-cut approach to obtain exact, optimal solutions. This program requires the ILOG CPLEX (IBM) optimization library that is available at no-charge for teaching and noncommercial research as part of the IBM Academic Initiative (IBM 2010). In the supplement of this article we provide a simple Python script for creating the input file for dhea-code from tab delimited text files of the weighted interactome and terminal nodes. The output files of dhea-code include the PCST solution in a DOT file [a plain text format for specifying graphs; (Graphviz 2011b)] . From there the solution can be rendered and viewed by the tools in Graphviz (Graphviz 2011a) , or further manipulated and analyzed by the Python library NetworkX (Hagberg et al. 2008) . One standard operation is to convert the DOT file to one of the files formats supported by Cytoscape (Smoot et al. 2011; Cline et al. 2007 ) in order to utilize Cytoscape's many visualization capabilities for biological networks.
A recently published message passing algorithm, although taking a heuristic approach, is able to find solutions with objective values comparable to dhea-code under much less computing time and memory (Bailly-Bechet et al. 2011). It requires a depth parameter to be specified a priori to control the length of paths in the solution network. This appears to have the consequence of eliminating long braches in the solution. The effect of this difference on the identities and functional relevance of the recovered nodes remains to be investigated.
III. Biological insights
The PCST solution connects together the phosphorylation events and transcriptional changes using a compact set of interactions. Since the method puts the phosphorylation events in the context of protein-protein interactions, the connections participated by these events or groups of events are suggestive of their cellular functions. The transcription factors included in the network and the connections among them point to the functional consequence of the upstream signals. These are certainly of great interest for elucidating the role of individual hits. Also interesting are the properties that emerge from the network at the systems level, and we will describe a few computational techniques for such analyses using the yeast pheromone response PCST solution as an example (Figure 2) .
A. Properties of the full network
The PCST solution in Figure 2 was constructed from published phosphoproteomic (Gruhler et al. 2005) and transcription profiling (Roberts et al. 2000) datasets of the yeast Saccharomyces cerevisiae in response to the mating pheromone α-factor. This network was first reported in ). The network connects 56 of the 112 proteins with α-factor-responsive phosphorylation sites and 100 of the 201 differentially expressed genes through 94 intermediate proteins.
The solution network shows a few notable features at the global level. First, the MAPK cascade known to be induced by pheromone (labeled "pheromone core" in Figure 2 ) is recovered by the algorithm. In particular, it correctly identifies the proteins GPA1, STE11 and BEM1, where no phosphorylation sites were detected, as well as their connections to other proteins in the pheromone signaling pathway. In addition, only proteins that are present in the pheromone response pathway are included. Secondly, beyond the MAPK cascade, the solution network partitions into highly coherent subnetworks with biological functions relevant to mating. At the transcription level, phosphorylated proteins seem highly informative in selecting interacting transcription factors. Examples include DIG1/DIG2/ STE12 complex in the pheromone signaling pathway, SWI4/SWI6 and SWI6/MBP1 in the PKC pathway, and FKH2/NDD1 complex regulated by CDC28. These observations suggest the constraints imposed by the phosphorylated proteins and differentially expressed genes are sufficient to guide the selection of important players that contribute to the response.
To assess the functional significance of the intermediate nodes from the PCST solution in mating response, we examined two independent whole-genome deletion screen datasets that screen for genes whose deletion result in mating defects. One screen measures a molecular phenotype in the form of activation of FUS1-lacZ reporter (Chasse et al. 2006 ) and the other screen measures a morphological phenotype in the form of cell cycle arrest and shmoo formation (Narayanaswamy et al. 2006 ). For each screen we counted the number of hits that overlap with the intermediate nodes in the PCST solution, and using all the screening genes as background we computed a hypergeometric P-value for which such overlap would appear by chance. As seen in Figure 4 , compared to networks constructed from shortest paths and first neighbors of the terminal nodes, the PCST solution is more compact while achieving higher enrichment of genes implicated in mating defects.
B. Biological functions of subnetwork/modules
To objectively quantify the empirical observation that the PCST solution is partitioned into functional coherent subnetworks, we applied the Girvan-Newman algorithm (Dunn et al. 2005; Girvan et al. 2002) to cluster the solution. This algorithm is used for detecting clusters in an interaction network that contain dense connections between nodes in the same cluster but less dense connections to nodes in other clusters. Gene Ontology enrichment analysis of the resulting clusters reveals that all the clusters have high degree of functional coherence (Table II) . It is interesting to note that many of the clusters are not coordinately expressed at the mRNA level, as quantified by the significance of expression coherence score or by the significance of expression activity score (Ideker et al. 2002) . Notably, the clusters that show significant coordinated expression are involved in cell cycle processes.
Being able to recover functionally coherent clusters that are not coherent at the transcript level is a significant result. Transcriptional data, which are more readily available than proteomics data, are the focus of many computational methods for regulatory network construction. Our results suggest that methods that rely solely on expression data, including a prior Steiner tree approach (Dittrich et al. 2008) , will be unable to recover the full extent of a biological response.
C. Quantifying the relevance of the transcription factors
In addition to the transcription factors mentioned above that are known to be induced by pheromone or function in related biological processes, the PCST solution network features many other transcriptional regulators not previously implicated in pheromone response. We use expression coherence score as a metric to quantify the significance of these transcription factors at the global level. For each transcription factor with targets in the interactome, we obtained the expression values of those targets across a set of conditions that stimulate pheromone signaling, and computed the significance P-value of the expression coherence score. Then we set a threshold on the significance P-value, and compared the percentage of transcription factors included and excluded in the PCST that pass this threshold. As shown in Figure 5 , the transcription factors included in the network are more likely to have a set of targets that are coherently expressed than the factors excluded from the network. To check if these transcription factors are condition specific, we did a similar calculation for the expression values from a set of conditions that are unrelated to pheromone: when yeast undergoes the metabolic shift from fermentation to respiration (diauxic shift). We found that coherence is specific to the conditions related to pheromone signaling but not to diauxic shift.
IV. Open challenges A. Improving the input data
The central premise behind our constraint optimization framework is that the experimental measurements at the signaling and transcription level are sufficient for guiding selection of relevant interactions from the interactome. It is important to note, however, that many of these interactions may only occur under specific conditions that are not relevant to the problem being studied. It is not yet practical to collect condition-specific interaction data on a large scale. Nevertheless, there are a few strategies to ensure the selected interactions are indeed relevant. First, as a pre-processing step, the input interaction network can be filtered to remove nodes that are not believed to be expressed under the condition of interest, based on transcript or protein assays. With the improved sensitivity of RNA-seq to detect low abundance transcripts compared to microarrays, this step may now be done with higher confidence. However, expression data are still noisy, and removing nodes completely risks missing important components of a network. Alternatively, we can add to the PCST formulation capacities on the nodes that represent the expression level. There are wellestablished procedures that transform node capacitated network flow problems to ones without the node capacities (Ahuja et al. 1995) .
Our current analysis defines node penalties on the phosphorylated proteins in a practical but ad hoc manner: the penalty values are proportional to the absolute value of log-fold changes of phosphorylation; if there are multiple phosphorylation sites on one protein, the maximum value is used. This reflects the assumption that larger changes in phosphorylation carry higher importance and thus should be given higher priority to be included. There are other, probably more principled, ways of quantifying the significance of the phosphorylation changes. We distinguish two kinds of significance: statistical significance and biological significance. The former requires the development of robust error models (Yi Zhang et al. 2010) while the latter would benefit from knowledge about the context of the phosphorylation sites, such as the structural domain or binding sequence motif where the sites are located [see examples in (Naegle et al. 2010) ]. But these two need not to be exclusive: once statistical significance is established, penalty values can be defined by analyzing for potential biological significance.
As phosphorylation sites are the starting point from which the PCST network solution is built, it is critical to have a good coverage of interactions involving these proteins in the interactome graph. Phosphorylation sites participate in interactions with other proteins in two ways: as substrates of kinase and phosphatases, and as binding partners of proteins that recognize the phosphorylated residues. Many of these interactions are transient and context specific and thus difficult to capture in some interaction assays. In particular, among the various high-throughput interactome mapping techniques, a modified affinity capture MS method is the most informative in identifying kinase targets, with yeast two-hybrid being second (Sharifpoor et al. 2011 ). Many in vivo methods are available to link kinases to phosphorylation substrates [reviewed in (Sopko et al. 2008) ] but only for specific kinases. Taking these efforts to the global level, and using other information such as sequence motifs integrated within a computational framework such as NetworKIN (Linding et al. 2007) , will produce interaction datasets that greatly enhance the ability of our algorithm to connect the phosphorylated proteins.
Beyond the focused mapping of interactions involving phosphorylated proteins, the ability to discover novel signaling pathways also depends on the coverage of other parts of the interactome. Even with the combination of large experimental efforts and curated databases we are still far from a complete mapping of all possible protein-protein interactions, especially in less well-studied organisms. Therefore, many computational methods have been developed to predict possible interactions. These methods make use of features such as gene neighborhood (M. Huynen et al. 2000) , gene fusion (Marcotte et al. 1999) , sequence co-evolution (Goh et al. 2000) , and may incorporate several such features in a Bayesian framework (Jansen et al. 2003) . The probabilistic nature of edge weights in our PCST formulation provides a natural way to include these computational predictions.
B. Other applications and potentials
The PCST approach can be used to analyze jointly a wide variety of types of data. Cellular functions are operated by networks of molecular interactions, which include a lot more than phosphorylation mediated signaling and transcription factor binding to target genes. But regardless of the data type, there are many situations in which we see to find a parsimonious, high-confidence interaction network satisfying a defined set of constraints. Therefore, this approach can be applied to many other levels of regulation, depending on the source of the constraints and the molecular interactions. For example, we may model the global effect of a microRNA by using the microRNA targets as constraints and including microRNA to target relationships in the interactome. Metabolomics data is another area of great interest and may become an entry point to link together protein signaling networks with metabolic networks. The detected metabolites can be used as constraints in a network of metabolic reactions catalyzed by enzymes that are also part of the protein interaction network. For all these datasets, taking a network approach such as the PCST will yield more insight than simply following up on the top hits.
One disadvantage of the PCST method is the tree structure of the resulting network: all the included terminal nodes must be connected to each other. However, it is possible that the terminal nodes belong to multiple, separate signaling pathways that are not connected to each other, either because there is no cross-talk biologically or the cross-talk interactions are not in the known interactome. Adopting a forest formulation, where multiple trees may be used to connect the terminal nodes, may remedy this drawback.
Finally, it is useful to consider this approach in the context of other types of network modeling. The strengths of our method lie in the ability to identify previously unrecognized components of a cellular response and to discover functionally coherent subsets of proteins. However, this approach is not designed to capture the dynamics of a system, including feedback regulation. A natural way to describe such feedback mathematically is by differential equations, which can be simulated numerically or analyzed. Differential equation-based models have been applied genome-wide in a comprehensive transcriptional and translational network for Escherichia coli (Thiele et al. 2009) and have been applied extensively to relatively small networks of mammalian proteins (Eungdamrong et al. 2004; Aldridge et al. 2006; Tyson et al. 2003) . However, such approaches are not suitable for very large networks where there are not enough data to sufficiently constrain the necessary parameters of the models.
We believe that these two approaches may ultimately be used together to develop dynamic models of previously uncharacterized biological systems. In a first phase, proteomic, transcriptional or other "-omics" datasets would be analyzed using constraint optimization to identify a set of proteins that seem most relevant to the biological process. With the size of the problem now reduced to a more manageable level, more focused experiments together with differential equation-based modeling could reveal the dynamics of the system.
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Refer to Web version on PubMed Central for supplementary material. (A) Finding relevant interactions as a constraint optimization problem. We seek a set of high confidence edges present in the interactome that directly or indirectly link the proteins and genes identified in the experimental assays. Because some of the input data may be false positives (arrowhead) or may not be explained by currently known interactome (arrow), our approach does not require that all the input data be connected, but rather uses these data as constraints. Note that the protein product and mRNA transcript of the same gene are represented as separate nodes. Image reproduced with permission from ). (B) Work flow diagram for defining the optimization objective function from input datasets. Interaction weights go into the edge cost summation term (Step 1) and the changes in tyrosine phosphorylation from MS data go into the node penalty summation term (Step 3). The transcription factor to mRNA target relationships are added to the edges to form the total interactome (Step 2), and the mRNA nodes are assigned penalty values (Step 3). The protein components of the pheromone response network constructed by the PCST approach. Note that the canonical pheromone response pathway (enclosed by dashed lines) is but a small component of the broad cellular changes revealed by applying the algorithm to the mass spectrometry and expression data. For clarity the differentially transcribed genes included in the network are not presented. Functional groups based on GO annotation are outlined with red boxes. PKC, protein kinase C; TF with phos. site, transcription factor with at least one differentially phosphorylated sites; TF with no phos. site, transcription factor with no differentially phosphorylated sites; non-TF protein with phos. site, a protein that is not a transcription factor and with at least one differentially phosphorylated sites; non-TF with no phos. site, a protein that is not a transcription factor and with no differentially phosphorylated sites. Image reproduced with permission from ). Alternative or suboptimal solutions to the yeast pheromone response dataset. Because we use an optimization approach to analyze inherently noisy data, we asked whether the network we obtained was stable -are there very different networks that explain the data almost as well? For this, we compared the optimal solution network to a set of alternative solution networks obtained by finding networks that are different from the optimal one by at least a specific percentage of nodes. (A) No alternative solutions in the neighborhood of the optimal solution achieve the same objective function value. (B) Of the nodes that appear at least once in the 54 suboptimal solutions, at least 80% also appear in the optimal solution. Image reproduced with permission from . The PCST pheromone response network is compact, and when compared to networks predicted by other methods, it contains higher fraction of genes that are implicated in mating response, measured by defects in activating a FUS1-lacZ reporter gene (Chasse et al. 2006) and defects in cell cycle arrest and shmoo formation (Narayanaswamy et al. 2006 ). The Flow network was constructed from the phosphorylated proteins and differential expressed genes by a previously published algorithm based on network flows (Yeger-Lotem et al. 2009 ). The Shortest path network consists of pairwise shortest paths between the terminal nodes and the First neighbor network consists of nodes in the interactome that directly interact with the phosphorylated proteins. Enrichment P-values were computed by hypergeometric tests using all the genes tested in the respective genetic screen as background. The number above each bar denotes the number of nodes in the network. Image reproduced with permission from . Percentage of transcription factors (TF) with targets that show significant expression coherence (EC) scores computed from 50 nM α-factor time course (Roberts et al. 2000) and diauxic shift conditions (DeRisi et al. 1997) , for transcription factors included in and excluded from the PCST solution network. The P-values indicate thresholds on the significance of the expression coherence score of the target genes. Image reproduced with permission from . Computational representation and discovery of transcription factor binding sites, with an example of the human REL protein binding profile [JASPAR MA0101.1, curated from Kunsch et al. (1992) ] and NFκB binding site in the human IL8 promoter (TRANSFAC binding site HS$IL8_21). In vitro techniques such as SELEX (systematic evolution of ligands by exponential enrichment) (Stoltenburg et al. 2007 ) can generate a set of sequences that bind to a specific transcription factor with high affinity. From an alignment of these sequences, a PFM is created to represent the base preference of this factor at each position of the binding site. After pseudo-count correction, the PSSM approach takes the base preference at each position, adjusts for background (usually genome-wide) frequency of that base, and computes a numerical value for the bases at each position that can be used to score a DNA sequence (D'haeseleer 2006; Stormo 2000) . Alternatively, an approximate PSAM for scoring can be created from a pseudo-count corrected PFM by calculating the preference of a base relative to the most frequent base at each position (Foat et al. 2006 (Foat et al. , 2005 Manke et al. 2008; Roider et al. 2007 ). See for a more detailed treatment of the topic. Table I A selection of publicly available protein-protein interaction databases. For further details see recent summary and reviews in . Many databases in this table have adopted the Proteomic Standards Initiative Molecular Interaction (PSI-MI) data formats and implemented the PSI Common Query Interface (PSICQUIC) ) that allows easy, programmatic access and integration of these data.
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